Kevin Sharer news from FierceBiotech
News
Amgen CEO: "I felt real economic pain"
What do you do when your biggest therapeutic earners are swooning, your stock price is down and analysts have turned scornful? Look for that silver lining. That was Read more...
Amgen CEO Kevin Sharer - CEO pay report
Kevin Sharer - Amgen Total Compensation: $19.9 million Details: Despite weathering its toughest year to date, Amgen CEO Kevin Sharer came out on top in this year's CEO pay ranking. However, Read more...
Troubled Amgen pays CEO $13.2M in compensation
With its shares plunging and regulators threatening its blockbuster anemia franchise, Amgen CEO Kevin Sharer (photo) nevertheless garnered $13.2 Read more...
Amgen CEO touts blockbuster potential of D-mab
Amgen CEO Kevin Sharer dropped by The Wall Street Journal to tout the company's chances in developing denosumab Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends